山东大学耳鼻喉眼学报 ›› 2025, Vol. 39 ›› Issue (2): 43-50.doi: 10.6040/j.issn.1673-3770.0.2024.357
• 论著 • 上一篇
曹正勇,李小波
CAO Zhengyong, LI Xiaobo
摘要: 目的 比较分析嗜酸性粒细胞慢性鼻-鼻窦炎伴鼻息肉(eosinophilic chronic rhinosinusitis with nasal polyps, eCRSwNP)合并哮喘术后短程局部使用糖皮质激素(布地奈德,鼻滴或喷雾)辅助糠酸莫米松治疗的安全性与有效性。 方法 将87例eCRSwNP合并哮喘术后患者随机分为3组,分别采用布地奈德鼻滴剂(A组,29例)和布地奈德鼻冲洗(B组,29例)联合糠酸莫米松鼻喷雾剂,与单独使用糠酸莫米松鼻喷雾剂(C组,29例)治疗。比较3组治疗1周后的症状减轻率、生活质量改善率及糖皮质激素治疗敏感率。于治疗第1 d(D1)、治疗第7 d(D7)、治疗1个月、3个月采用鼻部症状总分表(total nasal symptom scale, TNSS)、内镜鼻息肉评分(nasal polyp, NP)和中文版鼻腔鼻窦结局测试22(sinonasal outcome test-22, SNOT-22)评分评价患者的症状及生活质量改善情况。观察并比较3组不良反应发生情况。 结果 A组和B组治疗后1周的症状减轻率、生活质量改善率及糖皮质激素治疗敏感率均高于C组(P<0.05),但A组与B组差异无统计学意义(P>0.05)。治疗1周后,3组的TNSS、内镜NP和SNOT-22评分均显著降低,治疗后1个月、3个月均有降低趋势(P<0.05),A组和B组的评分显著低于C组(P<0.05),A组和B组差异无统计学意义(P>0.05)。3组均未发生严重不良反应。 结论 短程局部用糖皮质激素可用于治疗eCRSwNP合并哮喘,安全性较好。与单用糠酸莫米松鼻喷雾剂相比,布地奈德滴鼻剂联用糠酸莫米松鼻喷雾剂能够更好地改善临床症状,提高患者的生活质量。布地奈德滴鼻或鼻腔冲洗两种给药方式在治疗eCRSwNP合并哮喘患者的效果有可比性。
中图分类号:
[1] 胡守亮, 李辉, 朱天民, 等. 慢性鼻-鼻窦炎的病因及发病机制研究进展[J]. 实用医学杂志, 2019, 35(11): 1846-1849. doi:10.3969/j.issn.1006-5725.2019.11.033 HU Shouliang, LI Hui, ZHU Tianmin, et al. The Journal of Practical Medicine, 2019, 35(11): 1846-1849. doi:10.3969/j.issn.1006-5725.2019.11.033 [2] 王成硕, 张罗. 慢性鼻窦炎伴鼻息肉诊疗迈入精准治疗时代[J]. 中国耳鼻咽喉头颈外科, 2019, 26(12): 635-638. doi:10.16066/j.1672-7002.2019.12.001 WANG Chengshuo, ZHANG Luo. Precision medicine for chronic rhinosinusitis with nasal polyps[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2019, 26(12): 635-638. doi:10.16066/j.1672-7002.2019.12.001 [3] Lou HF, Zhang N, Bachert C, et al. Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement[J]. Int Forum Allergy Rhinol, 2018, 8(11): 1218-1225. doi:10.1002/alr.22214 [4] 陈兴雪, 张广玲, 武天义, 等. 抗IL-4Rα单克隆抗体与鼻内镜手术治疗嗜酸性粒细胞型慢性鼻窦炎伴鼻息肉的疗效分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 43-54. doi:10.6040/j.issn.1673-3770.0.2024.093 CHEN Xingxue, ZHANG Guangling, WU Tianyi, et al. Analysis of anti-IL-4Rα monoclonal antibody and endoscopic sinus surgery in the treatment of eosinophilic chronic rhino sinusitis with nasal polyps[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 43-54. doi:10.6040/j.issn.1673-3770.0.2024.093 [5] 崔宁, 王云梦, 杨景朴. 2型固有淋巴细胞在慢性鼻窦炎中的作用及调节机制研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(4): 153-159. doi:10.6040/j.issn.1673-3770.0.2022.192 CUI Ning, WANG Yunmeng, YANG Jingpu. Research progress on the role and regulatory mechanism of group 2 innate lymphoid cells in chronic rhino-sinusitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 153-159. doi:10.6040/j.issn.1673-3770.0.2022.192 [6] Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe[J]. Allergy, 2012, 67(1): 91-98. doi:10.1111/j.1398-9995.2011.02709.x [7] Cahill KN. Fevipiprant in CRSwNP and comorbid asthma: wrong target population or wrong PGD2 receptor?[J]. J Allergy Clin Immunol, 2022, 149(5): 1587-1589. doi:10.1016/j.jaci.2022.03.001 [8] 资昊坤,肖旭平,李云秋. 口服糖皮质激素在慢性鼻窦炎伴鼻息肉围手术期的应用现状[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 98-103. doi:10.6040/j.issn.1673-3770.0.2020.428 ZI Haokun, XIAO Xuping, LI Yunqiu. Application status of oral corticosteroids during the perioperative period of chronic rhinosinusitis with nasal polyps[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 98-103. doi:10.6040/j.issn.1673-3770.0.2020.428 [9] 张思远, 曹志伟. 口服糖皮质激素治疗慢性鼻-鼻窦炎伴鼻息肉[J]. 国际耳鼻咽喉头颈外科杂志, 2019, 43(4): 234-237. doi:10.3760/cma.j.issn.1673-4106.2019.04.012 ZHANG Siyuan, CAO Zhiwei. Oral glucocorticoids for chronic rhinosinusitis with nasal polyps[J]. International Journal of Otolaryngology-Head and Neck Surgery, 2019, 43(4): 234-237. doi:10.3760/cma.j.issn.1673-4106.2019.04.012 [10] 王阳, 黄嫣然, 娄鸿飞, 等. 三种激素剂型治疗嗜酸性粒细胞型鼻息肉的疗效及安全性研究[J]. 中国耳鼻咽喉头颈外科, 2019, 26(4): 199-203. doi:10.16066/j.1672-7002.2019.04.008 WANG Yang, HUANG Yanran, LOU Hongfei, et al. Efficacy and safety of three routes of corticosteroids in eosinophilic nasalpolyps[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2019, 26(4): 199-203. doi:10.16066/j.1672-7002.2019.04.008 [11] Neubauer PD, Schwam ZG, Peter Manes R. Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery[J]. Int Forum Allergy Rhinol, 2016, 6(3): 233-237. doi:10.1002/alr.21688 [12] 白玉, 李元惠, 高云海. 慢性鼻-鼻窦炎术前应用布地奈德联合鼻腔冲洗的临床疗效观察[J]. 北京医学, 2022, 44(9): 795-798. doi:10.15932/j.0253-9713.2022.09.005 BAI Yu, LI Yuanhui, GAO Yunhai. The clinical effect observation of budesonide combined with nasal irrigation before surgery in chronic rhinosinusitis[J]. Beijing Medical Journal, 2022, 44(9): 795-798. doi:10.15932/j.0253-9713.2022.09.005 [13] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(2): 81-100. doi:10.3760/cma.j.issn.1673-0860.2019.02.001 Subspecialty Group of Rhinology, Editorial Board of Chinese Journal of Otorhinolaryngology Head and NeckSurgery; Subspecialty Group of Rhinology, Society of Otorhinolaryngology Head and Neck Surgery, ChineseMedical Association. Chinese guidelines for diagnosis and treatment of chronic rhinosinusitis(2018)[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2019, 54(2): 81-100. doi:10.3760/cma.j.issn.1673-0860.2019.02.001 [14] Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(S29): 1-464. doi:10.4193/Rhin20.600 [15] 中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版)[J]. 中华结核和呼吸杂志, 2020, 43(12): 1023-1048. doi:10.3760/cma.j.cn112147-20200618-00721 Asthma group of Chinese Throacic Society. Guidelines for bronchial asthma prevent and management(2020 edition)Asthma group of Chinese Throacic Society[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2020, 43(12): 1023-1048. doi:10.3760/cma.j.cn112147-20200618-00721 [16] Xu ZF, Luo X, Xu L, et al. Effect of short-course glucocorticoid application on patients with chronic rhinosinusitis with nasal polyps[J]. World Allergy Organ J, 2020, 13(6): 100131. doi:10.1016/j.waojou.2020.100131 [17] Tamasauskiene L, Gasiuniene E, Sitkauskiene B. Translation, adaption and validation of the total nasal symptom score(TNSS)for Lithuanian population[J]. Health Qual Life Outcomes, 2021, 19(1): 54. doi:10.1186/s12955-020-01659-8 [18] Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: developing guidance for clinical trials[J]. J Allergy Clin Immunol, 2006, 118(5): 17-61. doi:10.1016/j.jaci.2006.09.005 [19] 吕威, 亓放, 高志强, 等. 汉化版SNOT-22评价慢性鼻-鼻窦炎患者生存质量的初步研究[J]. 中华耳鼻咽喉头颈外科杂志, 2008, 43(1): 18-21. doi:10.3321/j.issn: 1673-0860.2008.01.006 LÜ Wei, QI Fang, GAO Zhiqiang, et al. Quality of life survey on patients with chronic rhinosinusitis by using Chinese version of the 22-item sinonasal outcome test(SNOT-22)[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2008, 43(1): 18-21. doi:10.3321/j.issn: 1673-0860.2008.01.006 [20] 伏飞达, 杨明, 王旭, 等. 不同糖皮质激素对CRSwNP鼻内窥镜手术患者鼻黏膜功能、鼻黏膜重塑及术后出血的影响[J]. 川北医学院学报, 2022, 37(3): 290-293. doi:10.3969/j.issn.1005-3697.2022.03.004 FU Feida, YANG Ming, WANG Xu, et al. Effects of different glucocorticoids on nasal mucosa function, remodeling of nasal mucosa and postoperative bleeding in patients undergoing CRSwNP nasal endoscopic surgery[J]. Journal of North Sichuan Medical College, 2022, 37(3): 290-293. doi:10.3969/j.issn.1005-3697.2022.03.004 [21] Maza-Solano J, Callejon-Leblic A, Martin-Jimenez D, et al. Omalizumab treatment in uncontrolled asthma and CRSwNP patients, with previous endoscopic sinus surgery, to improve quality of life and endoscopic outcomes: a two-year real-life study[J]. Curr Allergy Asthma Rep, 2023, 23(10): 555-566. doi:10.1007/s11882-023-01106-w [22] Winblad L, Larsen CG, Håkansson K, et al. The risk of osteoporosis in oral steroid treatment for nasal polyposis: a systematic review[J]. Rhinology, 2017, 55(3): 195-201. doi:10.4193/Rhino15.367 [23] Ikeda K, Ito S, Hibiya R, et al. Postoperative management of eosinophilic chronic rhinosinusitis with nasal polyps: impact of high-dose corticosteroid nasal spray[J]. Int Arch Otorhinolaryngol, 2019, 23(1): 101-103. doi:10.1055/s-0038-1668515 [24] 孟凡超, 褚静元, 于向阳. 维生素D联合布地奈德喷鼻剂对慢性鼻-鼻窦炎患者术后治疗的效果[J]. 实用临床医学, 2021, 22(2):34-36,78. doi: 10.13764/j.cnki.lcsy.2021.02.012 MENG Fanchao, CHU Jingyuan, YU Xiangyang. Efficacy of vitamin D combined with budesonide nasal spray in postoperative patients with chronic rhinosinusitis[J]. Practical Clinical Medicine, 2021, 22(2):34-36,78. doi: 10.13764/j.cnki.lcsy.2021.02.012 [25] Moffa A, Costantino A, Rinaldi V, et al. Nasal delivery devices: a comparative study on cadaver model[J]. Biomed Res Int, 2019, 2019: 4602651. doi:10.1155/2019/4602651 [26] 杨双元, 杨婷, 李陈, 等. 慢性鼻窦炎术后局部激素不同给药方式的研究进展[J]. 中国耳鼻咽喉颅底外科杂志, 2021, 27(5): 606-610, 614. doi:10.11798/j.issn.1007-1520.202121006 YANG Shuangyuan, YANG Ting, LI Chen, et al. Research progress of local glucocorticoids administered in different ways after endoscopic sinus surgery for chronic sinusitis[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2021, 27(5): 606-610, 614. doi:10.11798/j.issn.1007-1520.202121006 [27] 龚燕茂. 鼻腔冲洗对合并鼻窦炎的哮喘患者哮喘控制的影响[J]. 航空航天医学杂志, 2020, 31(10): 1173-1174. doi:10.3969/j.issn.2095-1434.2020.10.009 [28] 张霞. 功能性鼻内镜手术联合糖皮质激素鼻腔冲洗对慢性鼻窦炎患者鼻黏膜纤毛功能及鼻腔微生态的影响[J]. 中国耳鼻咽喉头颈外科, 2022, 29(9): 602-603. doi:10.16066/j.1672-7002.2022.09.015 ZHANG Xia. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2022, 29(9): 602-603. doi:10.16066/j.1672-7002.2022.09.015 [29] 唐红莉. 慢性鼻窦炎鼻息肉经功能性鼻内镜术后鼻腔冲洗联合糠酸莫米松喷雾剂治疗疗效及并发症观察[J]. 贵州医药, 2021, 45(5): 725-726. doi:10.3969/j.issn.1000-744X.2021.05.020 [30] Huang ZZ, Chen XZ, Huang JC, et al. Budesonide nasal irrigation improved Lund-Kennedy endoscopic score of chronic rhinosinusitis patients after endoscopic sinus surgery[J]. Eur Arch Otorhinolaryngol, 2019, 276(5): 1397-1403. doi:10.1007/s00405-019-05327-6 |
[1] | 王振晓,时光刚,何明强,时蕾. 哮吼患者的治疗选择和管理策略[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 136-144. |
[2] | 陈兴雪,张广玲,武天义,王卫卫,孙占伟,李世超,王广科. 抗IL-4Rα单克隆抗体与鼻内镜手术治疗嗜酸性粒细胞型慢性鼻窦炎伴鼻息肉的疗效分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 43-54. |
[3] | 李淑婷,赵慧,司明威,崔文轩,杨梦瑶,王红. 无植物性外伤史患者感染真菌性眼内炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 103-108. |
[4] | 崇维琨,王娟. 联合应用奥马珠单抗在儿童中重度变应性哮喘合并慢性鼻窦炎中的疗效观察[J]. 山东大学耳鼻喉眼学报, 2024, 38(1): 21-26. |
[5] | 孙汐文,骆春雨,李志鹏,张维天. 铁死亡在呼吸道炎症性疾病中的作用及研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 24-32. |
[6] | 王丽雪,曾毅,王丽欣,彭先兵. 浸润毕罗芬明胶海绵在功能性鼻内镜鼻窦手术后应用效果的临床观察[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 16-25. |
[7] | 卢淦,邓玉琴,陶泽璋. 过敏性疾病与糖尿病的相关性及潜在关联机制[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 215-222. |
[8] | 袁玥,付圣尧,姜彦,陈敏. 细胞焦亡在慢性气道炎症性疾病中的研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(4): 166-171. |
[9] | 李聪,李玲,刘亭彦, 陈良. 氨基糖苷类抗生素耳毒性影响因素研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(2): 128-134. |
[10] | 孙艳,姚浩,顾黎安. 布地奈德联合盐酸氨溴索鼓室内注射治疗成人分泌性中耳炎的疗效研究[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 77-82. |
[11] | 王茜,刘娜,王少鹏. Leber特发性星芒状视神经视网膜炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 106-110. |
[12] | 资昊坤,肖旭平,李云秋. 口服糖皮质激素在慢性鼻窦炎伴鼻息肉围手术期的应用现状[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 98-103. |
[13] | 王娜,柴向斌. 前列腺源性ETS因子在哮喘及鼻黏膜炎性疾病中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 136-141. |
[14] | 陈世琴,卫平存,胡云龙,胡金旺. 糖皮质激素三种不同鼻用法对鼻内镜术后黏膜转归的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 195-201. |
[15] | 李孟辉,郅莉莉,戚凯文,王珊珊,高倩,步美玲,姜荷云,冯绛楠,王金荣. 皮下免疫治疗对单一尘螨和合并霉菌过敏儿童哮喘的临床研究[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 75-80. |
|